Disease-modifying strategies in primary tauopathies

Area of Science:

• Neuroscience
• Pathology
• Pharmacology

Background:

• Tauopathies are neurodegenerative diseases defined by tau protein inclusions in neurons.
• These conditions lead to progressive brain degeneration affecting language, behavior, and movement.

Purpose of the Study:

• To provide an updated overview of therapeutic targets in primary tauopathies.
• To discuss potential disease-modifying therapeutic strategies for tauopathies.

Main Methods:

• Review of current literature on tauopathy mechanisms and therapeutic targets.
• Structured analysis of four key target areas: tau modification/aggregation, protein homeostasis, disease propagation, and genetics.

Main Results:

• Identified key targets including post-translational modifications of tau, protein homeostasis, disease spread, and tau genetics.
• Highlighted both opportunities and challenges in developing effective tauopathy therapies.

Conclusions:

• Therapeutic strategies such as immunization and proteostasis modulation show promise for tauopathies.
• Several strategies are advancing to clinical development, offering hope for patients.